Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme

Authors: Kudakwashe C Takarinda, Anthony D Harries, Barnet Nyathi, Mkhokheli Ngwenya, Tsitsi Mutasa-Apollo, Charles Sandy

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Delayed presentation of pulmonary TB (PTB) patients for treatment from onset of symptoms remains a threat to controlling individual disease progression and TB transmission in the community. Currently, there is insufficient information about treatment delays in Zimbabwe, and we therefore determined the extent of patient and health systems delays and their associated factors in patients with microbiologically confirmed PTB.

Methods

A structured questionnaire was administered at 47 randomly selected health facilities in Zimbabwe by trained health workers to all patients aged ≥18 years with microbiologically confirmed PTB who were started on TB treatment and entered in the health facility TB registers between 01 January and 31 March 2013. Multivariate logistic regression was used to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CIs) for associations between patient/health system characteristics and patient delay >30 days or health system delay >4 days.

Results

Of the 383 recruited patients, 211(55%) were male with an overall median age of 34 years (IQR, 28-43). There was a median of 28 days (IQR, 21-63) for patient delays and 2 days (IQR, 1-5) for health system delays with 184 (48%) and 118 (31%) TB patients experiencing health system delays >30 days and health system delays >4 days respectively. Starting TB treatment at rural primary healthcare vs district/mission facilities [aOR 2.70, 95% CI 1.27-5.75, p = 0.01] and taking self-medication [aOR 2.33, 95% CI 1.23-4.43, p = 0.01] were associated with encountering patient delays. Associated with health system delays were accessing treatment from lower level facilities [aOR 2.67, 95% CI 1.18-6.07, p = 0.019], having a Gene Xpert TB diagnosis [aOR 0.21, 95% CI 0.07-0.66, p = 0.008] and >4 health facility visits prior to TB diagnosis [(aOR) 3.34, 95% CI 1.11-10.03, p = 0.045].

Conclusion

Patient delays were longer and more prevalent, suggesting the need for strategies aimed at promoting timely seeking of appropriate medical consultation among presumptive TB patients. Health system delays were uncommon, suggesting a fairly efficient response to microbiologically confirmed PTB cases. Identified risk factors should be explored further and specific strategies aimed at addressing these factors should be identified in order to lessen patient and health system delays.
Literature
1.
2.
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163 Suppl 9:1009–21.CrossRefPubMed
3.
Pablos-Méndez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996;276 Suppl 15:1223–8.CrossRefPubMed
4.
Aït-Khaled N, Alarcón E, Armengol R, Bissell K, Boillot F, Cameniro JA, et al. Management of tuberculosis: a guide to the essentials of good practice. 6th ed. Paris, France: International Union Against Tuberculosis and Lung Disease; 2010.
5.
Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis. 2009;9:91.CrossRefPubMedPubMedCentral
6.
7.
Finnie RKC, Khoza LB, van den Borne B, Mabunda T, Abotchie P, Mullen PD. Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high burdens of TB and HIV. Trop Med Int Health. 2011;16(4):394–411.CrossRefPubMed
8.
9.
Ministry of Health and Child Welfare Zimbabwe. Zimbabwe National Tuberculosis Control Programme Manual. 4th ed. Harare, Zimbabwe: Ministry of Health and Child Welfare; 2010.
10.
Ministry of Health and Child Welfare Zimbabwe. National HIV Testing and Counselling Trainee’s Manual. Harare, Zimbabwe: Ministry of Health and Child Welfare; 2007.
11.
Ministry of Health and Child Welfare Zimbabwe. National Guidelines for TB/HIV Co-management. Harare, Zimbabwe: Ministry of Health and Child Welfare; 2007.
12.
World Health Organisation (WHO) Regional Office for the Eastern Mediterranean: Diagnostic and treatment delay in tuberculosis: An in-depth analysis of the health seeking behaviour of patients and health system response in seven countries of the Eastern Mediterranean Region. Cairo, Egypt: WHO; 2006.[http://​applications.​emro.​who.​int/​dsaf/​dsa710.​pdf]
13.
Lusignani LS, Quaglio G, Atzori A, Nsuka J, Grainger R, Da Conceicao PM, et al. Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda, Angola. BMC Infect Dis. 2013;13 Suppl 1:168.CrossRef
14.
Wandwalo ER, Mørkve O. Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania. Int J Tuberc Lung Dis. 2000;4 Suppl 2:133–8.PubMed
15.
Lawn SD, Afful B, Acheampong JW. Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis. 1998;2 Suppl 8:635–40.PubMed
16.
Pronyk RM, Makhubele MB, Hargreaves JR, Tollman SM, Hausler HP. Assessing health seeking behavior in rural South Africa. Int J Tuberc Lung Dis. 2001;5 Suppl 7:619–27.PubMed
17.
Yimer S, Bjune G, Alene G. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005;5:112.CrossRefPubMedPubMedCentral
18.
Liam CK, Tang BG. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital. Int J Tuberc Lung Dis. 1997;1 Suppl 4:326–32.PubMed
19.
Kiwuwa MS, Charles K, Harriet MK. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health. 2005;5:122.CrossRefPubMedPubMedCentral
20.
Rojpibulstit M, Kanjanakiritamrong J, Chongsuvivatwong V. Patient and health system delays in the diagnosis of tuberculosis in Southern Thailand after health care reform. Int J Tuberc Lung Dis. 2006;10 Suppl 4:422–8.PubMed
21.
Needham DM, Foster SD, Tomlinson G, Godfrey-Faussett P. Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health. 2001;6 Suppl 4:256–9.CrossRefPubMed
22.
Lienhardt C, Rowley J, Manneh K, Lahai G, Needham D, Milligan P, et al. Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis. 2001;5 Suppl 3:233–9.PubMed
23.
Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006;1:e121.CrossRefPubMedPubMedCentral
24.
Cambanis A, Yassin MA, Ramsay A, Bertel Squire S, Arbide I, Cuevas LE. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Trop Med Int Health. 2005;10 Suppl 4:330–5.CrossRefPubMed
25.
Ukwaja KN, Alobu I, Nweke CO, Onyenwe EC. Healthcare-seeking behavior, treatment delays and its determinants among pulmonary tuberculosis patients in rural Nigeria: a cross-sectional study. BMC Health Serv Res. 2013;13:25.CrossRefPubMedPubMedCentral
26.
Pirkis JE, Speed BR, Yung AP, Dunt DR, MacIntyre CR, Plant AJ. Time to initiation of anti-tuberculosis treatment. Tuber Lung Dis. 1996;77 Suppl 5:401–6.CrossRefPubMed
27.
Güneylioglu D, Yilmaz A, Bilgin S, Bayram U, Akkaya E. Factors affecting delays in diagnosis and treatment of pulmonary tuberculosis in a tertiary care hospital in Istanbul. Turkey Med Sci Monit. 2004;10 Suppl 2:CR62–7.PubMed
28.
Ngamvithayapong J, Yanai H, Winkvist A, Diwan V. Health seeking behaviour and diagnosis for pulmonary tuberculosis in an HIV-epidemic mountainous area of Thailand. Int J Tuberc Lung Dis. 2001;5 Suppl 11:1013–20.PubMed
29.
Demissie M, Lindtjorn B, Berhane Y. Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health. 2002;25 Suppl 2:23.CrossRef
30.
Long NH, Johansson E, Lonnroth K, Eriksson B, Winkvist A, Diwan VK. Longer delays in tuberculosis diagnosis among women in Vietnam. Int J Tuberc Lung Dis. 1999;3 Suppl 5:388–93.PubMed
31.
Jurcev-Savicevic A, Mulic R, Kozul K, Ban B, Valic J, Bacun-Ivek L, et al. Health system delay in pulmonary tuberculosis treatment in a country with an intermediate burden of tuberculosis: a cross-sectional study. BMC Public Health. 2013;13:250.CrossRefPubMedPubMedCentral
32.
Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Sys Rev. 2013;1:CD009593.
33.
Ministry of Health and Child Care. Guidelines for the Programmatic Management Of Drug Resistant Tuberculosis in Zimbabwe. Harare, Zimbabwe: Ministry of Health and Child Care; 2013.
34.
35.
Ministry of Health and Child Welfare Zimbabwe (MOHCW), Central Statistical Office (CSO). National Health Profile 2006. Harare, Zimbabwe: MOHCW and CSO; 2006.
36.
37.
Xu X, Liu J-H, Cao S-Y, Zhao Y, Dong X-X, Liang Y, et al. Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China. Int J Tuberc Lung Dis. 2013;17 Suppl 5:615–20.CrossRefPubMed
38.
Murimwa TC, Sandy C, Mugurungi O, Edginton ME, Reid T. What proportion of patients diagnosed with TB and started on treatment in Manicaland Province, Zimbabwe, are registered? Int Health. 2012;4 Suppl 4:320–2.CrossRefPubMed
39.
Metadata
Title
Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme
Authors
Kudakwashe C Takarinda
Anthony D Harries
Barnet Nyathi
Mkhokheli Ngwenya
Tsitsi Mutasa-Apollo
Charles Sandy
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1437-7

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study

Study protocol

Family planning to promote physical activity: a randomized controlled trial protocol

Research article

Impact of male partner’s awareness and support for contraceptives on female intent to use contraceptives in southeast Nigeria

Research article

Surveillance systems evaluation: a systematic review of the existing approaches

Research article

Development of a Canadian socioeconomic status index for the study of health outcomes related to environmental pollution

Research article

Barriers to modern contraceptive methods uptake among young women in Kenya: a qualitative study